Aβ	Amyloid-β
ACh	Acetylcholine
AChE	Acetylcholinesterase
AChEi	Acetylcholinesterase inhibitor(s)
AD	Alzheimer’s disease
ADME	Absorption, distribution, metabolism, and excretion
APP	Amyloid precursor protein
BACE1	β-Secretase 1
BACE1i	β-Secretase 1 inhibitor(s)
BBB	Blood-brain barrier
CA	Carbonic anhydrase
CAi	Carbonic anhydrase inhibitor(s)
CAS	Catalytic active site
CNS	Central nervous system
COX-2	Cyclooxygenase 2
DABCO	1,4-Diazabicyclo[2.2.2]octane
DCE	Dichloroethane
DCM	Dichloromethane
DIPEA	N,N-Diisopropylethylamine
DMF	Dimethylformamide
DMSO	Dimethyl sulfoxide
Ee	Electrophorus electricus
GSH	Glutathione
h	Human
HATU	1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate
IC50	Half maximal inhibitory concentration
KA	Kojic acid
15-LOX	15-Lipoxygenase
MOA	Monoamine oxidase
MOAi	Monoamine oxidase inhibitor(s)
MTDL	Multitarget-directed ligand
MWI	Microwave irradiation
NFTs	Neurofibrillary tangles
NMDAR	N-methyl-d-aspartate receptor
ORAC	Oxygen radical absorbance capacity
PAMPA	Parallel artificial membrane permeability assay
PAS	Peripheral anionic site
Pe	Effective permeability
ROS	Reactive oxygen species
SAR	Structure-activity relationship
SGPT	Serum glutamic pyruvic transaminase
Tc	Torpedo californica
TEA	Triethylamine
TFAA	Trifluoroacetic anhydride
THF	Tetrahydrofuran
T3P	Propylphosphonic anhydride